Zepbound is a weekly injectable designed to support long-term weight loss by targeting underlying biological drivers of obesity, explains Rekha Kumar, MS, MD, endocrinologist, obesity medicine specialist and Senior Medical Advisor at Found
Clinical trial data submitted to regulatory authorities, including the MHRA and European Medicines Agency (EMA), document headache as an adverse event across different GLP-1 medications, with varying frequencies depending on the specific drug and dosage
Typically taken once daily, in the recommended dose
Doctors sometimes prescribe Mounjaro off-label for weight loss because it is approved for diabetes and is covered more reliably than Zepbound
TBK1 can phosphorylate and activate regulatory-associated protein of mTOR (RAPTOR), which decreases activity of mTORC1 and promotes autophagy (173)
Aim for 1.6-2.2 grams of protein per kilogram of body weight, depending on your activity level